Volgograd State Medical University   Report issue

Academic/Hospital Phase 4
Founded: Volgograd Russian Federation (1935)

Organization Overview

First Clinical Trial
2019
NCT04023565
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sergey V. Nedogoda | Volgograd State Medical University

Active Ingredients

Drugs in Phase 4 Trials (2)

moxonidine (1 trial)

perindopril (aceon) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Metabolic Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2